0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Preclinical In-vivo Imaging System Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-30B9595
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Preclinical In vivo Imaging System Market Insights Forecast to 2028
BUY CHAPTERS

Global Preclinical In-vivo Imaging System Market Research Report 2024

Code: QYRE-Auto-30B9595
Report
March 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Preclinical In-vivo Imaging System Market

Preclinical In-vivo Imaging System is a collective name for various types of remote sensor systems that acquire non-photographic remote sensing images of ground objects. Scanning is usually used to allow the observer to observe the conditions in the human or animal body.
The global Preclinical In-vivo Imaging System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Preclinical In-vivo Imaging System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preclinical In-vivo Imaging System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Preclinical In-vivo Imaging System include Siemens A.G., General Electric(GE), Agilent Technologies, FUJIFILM VisualSonics, Aspect Imaging, Biospace Lab SA, Bruker Corporation, LI-COR Biosciences and Mesoso Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preclinical In-vivo Imaging System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical In-vivo Imaging System.

Report Scope

The Preclinical In-vivo Imaging System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical In-vivo Imaging System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical In-vivo Imaging System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Preclinical In-vivo Imaging System Market Report

Report Metric Details
Report Name Preclinical In-vivo Imaging System Market
Segment by Type
  • Optical Imaging System
  • Nuclear Imaging System
  • Micro MRI System
  • Micro CT System
  • Micro Ultrasound System
  • Photoacoustic and Magnetic Particle Imaging Systems
Segment by Application
  • Hospitals
  • Veterinary Clinics
  • Laboratory
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Siemens A.G., General Electric(GE), Agilent Technologies, FUJIFILM VisualSonics, Aspect Imaging, Biospace Lab SA, Bruker Corporation, LI-COR Biosciences, Mesoso Ltd., MIlabs BV, MR Solutions Ltd, PerkinElmer, TriFoil Imaging
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Preclinical In-vivo Imaging System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Preclinical In-vivo Imaging System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Preclinical In-vivo Imaging System Market report?

Ans: The main players in the Preclinical In-vivo Imaging System Market are Siemens A.G., General Electric(GE), Agilent Technologies, FUJIFILM VisualSonics, Aspect Imaging, Biospace Lab SA, Bruker Corporation, LI-COR Biosciences, Mesoso Ltd., MIlabs BV, MR Solutions Ltd, PerkinElmer, TriFoil Imaging

What are the Application segmentation covered in the Preclinical In-vivo Imaging System Market report?

Ans: The Applications covered in the Preclinical In-vivo Imaging System Market report are Hospitals, Veterinary Clinics, Laboratory, Other

What are the Type segmentation covered in the Preclinical In-vivo Imaging System Market report?

Ans: The Types covered in the Preclinical In-vivo Imaging System Market report are Optical Imaging System, Nuclear Imaging System, Micro MRI System, Micro CT System, Micro Ultrasound System, Photoacoustic and Magnetic Particle Imaging Systems

1 Preclinical In-vivo Imaging System Market Overview
1.1 Product Overview and Scope of Preclinical In-vivo Imaging System
1.2 Preclinical In-vivo Imaging System Segment by Type
1.2.1 Global Preclinical In-vivo Imaging System Market Value Comparison by Type (2024-2030)
1.2.2 Optical Imaging System
1.2.3 Nuclear Imaging System
1.2.4 Micro MRI System
1.2.5 Micro CT System
1.2.6 Micro Ultrasound System
1.2.7 Photoacoustic and Magnetic Particle Imaging Systems
1.3 Preclinical In-vivo Imaging System Segment by Application
1.3.1 Global Preclinical In-vivo Imaging System Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Veterinary Clinics
1.3.4 Laboratory
1.3.5 Other
1.4 Global Preclinical In-vivo Imaging System Market Size Estimates and Forecasts
1.4.1 Global Preclinical In-vivo Imaging System Revenue 2019-2030
1.4.2 Global Preclinical In-vivo Imaging System Sales 2019-2030
1.4.3 Global Preclinical In-vivo Imaging System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Preclinical In-vivo Imaging System Market Competition by Manufacturers
2.1 Global Preclinical In-vivo Imaging System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Preclinical In-vivo Imaging System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Preclinical In-vivo Imaging System Average Price by Manufacturers (2019-2024)
2.4 Global Preclinical In-vivo Imaging System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Preclinical In-vivo Imaging System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Preclinical In-vivo Imaging System, Product Type & Application
2.7 Preclinical In-vivo Imaging System Market Competitive Situation and Trends
2.7.1 Preclinical In-vivo Imaging System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Preclinical In-vivo Imaging System Players Market Share by Revenue
2.7.3 Global Preclinical In-vivo Imaging System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Preclinical In-vivo Imaging System Retrospective Market Scenario by Region
3.1 Global Preclinical In-vivo Imaging System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Preclinical In-vivo Imaging System Global Preclinical In-vivo Imaging System Sales by Region: 2019-2030
3.2.1 Global Preclinical In-vivo Imaging System Sales by Region: 2019-2024
3.2.2 Global Preclinical In-vivo Imaging System Sales by Region: 2025-2030
3.3 Global Preclinical In-vivo Imaging System Global Preclinical In-vivo Imaging System Revenue by Region: 2019-2030
3.3.1 Global Preclinical In-vivo Imaging System Revenue by Region: 2019-2024
3.3.2 Global Preclinical In-vivo Imaging System Revenue by Region: 2025-2030
3.4 North America Preclinical In-vivo Imaging System Market Facts & Figures by Country
3.4.1 North America Preclinical In-vivo Imaging System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Preclinical In-vivo Imaging System Sales by Country (2019-2030)
3.4.3 North America Preclinical In-vivo Imaging System Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Preclinical In-vivo Imaging System Market Facts & Figures by Country
3.5.1 Europe Preclinical In-vivo Imaging System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Preclinical In-vivo Imaging System Sales by Country (2019-2030)
3.5.3 Europe Preclinical In-vivo Imaging System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Preclinical In-vivo Imaging System Market Facts & Figures by Country
3.6.1 Asia Pacific Preclinical In-vivo Imaging System Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Preclinical In-vivo Imaging System Sales by Country (2019-2030)
3.6.3 Asia Pacific Preclinical In-vivo Imaging System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Preclinical In-vivo Imaging System Market Facts & Figures by Country
3.7.1 Latin America Preclinical In-vivo Imaging System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Preclinical In-vivo Imaging System Sales by Country (2019-2030)
3.7.3 Latin America Preclinical In-vivo Imaging System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Preclinical In-vivo Imaging System Market Facts & Figures by Country
3.8.1 Middle East and Africa Preclinical In-vivo Imaging System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Preclinical In-vivo Imaging System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Preclinical In-vivo Imaging System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Preclinical In-vivo Imaging System Sales by Type (2019-2030)
4.1.1 Global Preclinical In-vivo Imaging System Sales by Type (2019-2024)
4.1.2 Global Preclinical In-vivo Imaging System Sales by Type (2025-2030)
4.1.3 Global Preclinical In-vivo Imaging System Sales Market Share by Type (2019-2030)
4.2 Global Preclinical In-vivo Imaging System Revenue by Type (2019-2030)
4.2.1 Global Preclinical In-vivo Imaging System Revenue by Type (2019-2024)
4.2.2 Global Preclinical In-vivo Imaging System Revenue by Type (2025-2030)
4.2.3 Global Preclinical In-vivo Imaging System Revenue Market Share by Type (2019-2030)
4.3 Global Preclinical In-vivo Imaging System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Preclinical In-vivo Imaging System Sales by Application (2019-2030)
5.1.1 Global Preclinical In-vivo Imaging System Sales by Application (2019-2024)
5.1.2 Global Preclinical In-vivo Imaging System Sales by Application (2025-2030)
5.1.3 Global Preclinical In-vivo Imaging System Sales Market Share by Application (2019-2030)
5.2 Global Preclinical In-vivo Imaging System Revenue by Application (2019-2030)
5.2.1 Global Preclinical In-vivo Imaging System Revenue by Application (2019-2024)
5.2.2 Global Preclinical In-vivo Imaging System Revenue by Application (2025-2030)
5.2.3 Global Preclinical In-vivo Imaging System Revenue Market Share by Application (2019-2030)
5.3 Global Preclinical In-vivo Imaging System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Siemens A.G.
6.1.1 Siemens A.G. Corporation Information
6.1.2 Siemens A.G. Description and Business Overview
6.1.3 Siemens A.G. Preclinical In-vivo Imaging System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Siemens A.G. Preclinical In-vivo Imaging System Product Portfolio
6.1.5 Siemens A.G. Recent Developments/Updates
6.2 General Electric(GE)
6.2.1 General Electric(GE) Corporation Information
6.2.2 General Electric(GE) Description and Business Overview
6.2.3 General Electric(GE) Preclinical In-vivo Imaging System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 General Electric(GE) Preclinical In-vivo Imaging System Product Portfolio
6.2.5 General Electric(GE) Recent Developments/Updates
6.3 Agilent Technologies
6.3.1 Agilent Technologies Corporation Information
6.3.2 Agilent Technologies Description and Business Overview
6.3.3 Agilent Technologies Preclinical In-vivo Imaging System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Agilent Technologies Preclinical In-vivo Imaging System Product Portfolio
6.3.5 Agilent Technologies Recent Developments/Updates
6.4 FUJIFILM VisualSonics
6.4.1 FUJIFILM VisualSonics Corporation Information
6.4.2 FUJIFILM VisualSonics Description and Business Overview
6.4.3 FUJIFILM VisualSonics Preclinical In-vivo Imaging System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 FUJIFILM VisualSonics Preclinical In-vivo Imaging System Product Portfolio
6.4.5 FUJIFILM VisualSonics Recent Developments/Updates
6.5 Aspect Imaging
6.5.1 Aspect Imaging Corporation Information
6.5.2 Aspect Imaging Description and Business Overview
6.5.3 Aspect Imaging Preclinical In-vivo Imaging System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aspect Imaging Preclinical In-vivo Imaging System Product Portfolio
6.5.5 Aspect Imaging Recent Developments/Updates
6.6 Biospace Lab SA
6.6.1 Biospace Lab SA Corporation Information
6.6.2 Biospace Lab SA Description and Business Overview
6.6.3 Biospace Lab SA Preclinical In-vivo Imaging System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biospace Lab SA Preclinical In-vivo Imaging System Product Portfolio
6.6.5 Biospace Lab SA Recent Developments/Updates
6.7 Bruker Corporation
6.6.1 Bruker Corporation Corporation Information
6.6.2 Bruker Corporation Description and Business Overview
6.6.3 Bruker Corporation Preclinical In-vivo Imaging System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bruker Corporation Preclinical In-vivo Imaging System Product Portfolio
6.7.5 Bruker Corporation Recent Developments/Updates
6.8 LI-COR Biosciences
6.8.1 LI-COR Biosciences Corporation Information
6.8.2 LI-COR Biosciences Description and Business Overview
6.8.3 LI-COR Biosciences Preclinical In-vivo Imaging System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 LI-COR Biosciences Preclinical In-vivo Imaging System Product Portfolio
6.8.5 LI-COR Biosciences Recent Developments/Updates
6.9 Mesoso Ltd.
6.9.1 Mesoso Ltd. Corporation Information
6.9.2 Mesoso Ltd. Description and Business Overview
6.9.3 Mesoso Ltd. Preclinical In-vivo Imaging System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mesoso Ltd. Preclinical In-vivo Imaging System Product Portfolio
6.9.5 Mesoso Ltd. Recent Developments/Updates
6.10 MIlabs BV
6.10.1 MIlabs BV Corporation Information
6.10.2 MIlabs BV Description and Business Overview
6.10.3 MIlabs BV Preclinical In-vivo Imaging System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 MIlabs BV Preclinical In-vivo Imaging System Product Portfolio
6.10.5 MIlabs BV Recent Developments/Updates
6.11 MR Solutions Ltd
6.11.1 MR Solutions Ltd Corporation Information
6.11.2 MR Solutions Ltd Preclinical In-vivo Imaging System Description and Business Overview
6.11.3 MR Solutions Ltd Preclinical In-vivo Imaging System Sales, Revenue and Gross Margin (2019-2024)
6.11.4 MR Solutions Ltd Preclinical In-vivo Imaging System Product Portfolio
6.11.5 MR Solutions Ltd Recent Developments/Updates
6.12 PerkinElmer
6.12.1 PerkinElmer Corporation Information
6.12.2 PerkinElmer Preclinical In-vivo Imaging System Description and Business Overview
6.12.3 PerkinElmer Preclinical In-vivo Imaging System Sales, Revenue and Gross Margin (2019-2024)
6.12.4 PerkinElmer Preclinical In-vivo Imaging System Product Portfolio
6.12.5 PerkinElmer Recent Developments/Updates
6.13 TriFoil Imaging
6.13.1 TriFoil Imaging Corporation Information
6.13.2 TriFoil Imaging Preclinical In-vivo Imaging System Description and Business Overview
6.13.3 TriFoil Imaging Preclinical In-vivo Imaging System Sales, Revenue and Gross Margin (2019-2024)
6.13.4 TriFoil Imaging Preclinical In-vivo Imaging System Product Portfolio
6.13.5 TriFoil Imaging Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Preclinical In-vivo Imaging System Industry Chain Analysis
7.2 Preclinical In-vivo Imaging System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Preclinical In-vivo Imaging System Production Mode & Process
7.4 Preclinical In-vivo Imaging System Sales and Marketing
7.4.1 Preclinical In-vivo Imaging System Sales Channels
7.4.2 Preclinical In-vivo Imaging System Distributors
7.5 Preclinical In-vivo Imaging System Customers
8 Preclinical In-vivo Imaging System Market Dynamics
8.1 Preclinical In-vivo Imaging System Industry Trends
8.2 Preclinical In-vivo Imaging System Market Drivers
8.3 Preclinical In-vivo Imaging System Market Challenges
8.4 Preclinical In-vivo Imaging System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Preclinical In-vivo Imaging System Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Preclinical In-vivo Imaging System Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Preclinical In-vivo Imaging System Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Preclinical In-vivo Imaging System Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Preclinical In-vivo Imaging System Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Preclinical In-vivo Imaging System Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Preclinical In-vivo Imaging System Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Preclinical In-vivo Imaging System Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Preclinical In-vivo Imaging System, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Preclinical In-vivo Imaging System, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Preclinical In-vivo Imaging System, Product Type & Application
    Table 12. Global Key Manufacturers of Preclinical In-vivo Imaging System, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Preclinical In-vivo Imaging System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical In-vivo Imaging System as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Preclinical In-vivo Imaging System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Preclinical In-vivo Imaging System Sales by Region (2019-2024) & (K Units)
    Table 18. Global Preclinical In-vivo Imaging System Sales Market Share by Region (2019-2024)
    Table 19. Global Preclinical In-vivo Imaging System Sales by Region (2025-2030) & (K Units)
    Table 20. Global Preclinical In-vivo Imaging System Sales Market Share by Region (2025-2030)
    Table 21. Global Preclinical In-vivo Imaging System Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Preclinical In-vivo Imaging System Revenue Market Share by Region (2019-2024)
    Table 23. Global Preclinical In-vivo Imaging System Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Preclinical In-vivo Imaging System Revenue Market Share by Region (2025-2030)
    Table 25. North America Preclinical In-vivo Imaging System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Preclinical In-vivo Imaging System Sales by Country (2019-2024) & (K Units)
    Table 27. North America Preclinical In-vivo Imaging System Sales by Country (2025-2030) & (K Units)
    Table 28. North America Preclinical In-vivo Imaging System Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Preclinical In-vivo Imaging System Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Preclinical In-vivo Imaging System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Preclinical In-vivo Imaging System Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Preclinical In-vivo Imaging System Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Preclinical In-vivo Imaging System Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Preclinical In-vivo Imaging System Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Preclinical In-vivo Imaging System Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Preclinical In-vivo Imaging System Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Preclinical In-vivo Imaging System Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Preclinical In-vivo Imaging System Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Preclinical In-vivo Imaging System Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Preclinical In-vivo Imaging System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Preclinical In-vivo Imaging System Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Preclinical In-vivo Imaging System Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Preclinical In-vivo Imaging System Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Preclinical In-vivo Imaging System Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Preclinical In-vivo Imaging System Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Preclinical In-vivo Imaging System Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Preclinical In-vivo Imaging System Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Preclinical In-vivo Imaging System Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Preclinical In-vivo Imaging System Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Preclinical In-vivo Imaging System Sales (K Units) by Type (2019-2024)
    Table 51. Global Preclinical In-vivo Imaging System Sales (K Units) by Type (2025-2030)
    Table 52. Global Preclinical In-vivo Imaging System Sales Market Share by Type (2019-2024)
    Table 53. Global Preclinical In-vivo Imaging System Sales Market Share by Type (2025-2030)
    Table 54. Global Preclinical In-vivo Imaging System Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Preclinical In-vivo Imaging System Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Preclinical In-vivo Imaging System Revenue Market Share by Type (2019-2024)
    Table 57. Global Preclinical In-vivo Imaging System Revenue Market Share by Type (2025-2030)
    Table 58. Global Preclinical In-vivo Imaging System Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Preclinical In-vivo Imaging System Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Preclinical In-vivo Imaging System Sales (K Units) by Application (2019-2024)
    Table 61. Global Preclinical In-vivo Imaging System Sales (K Units) by Application (2025-2030)
    Table 62. Global Preclinical In-vivo Imaging System Sales Market Share by Application (2019-2024)
    Table 63. Global Preclinical In-vivo Imaging System Sales Market Share by Application (2025-2030)
    Table 64. Global Preclinical In-vivo Imaging System Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Preclinical In-vivo Imaging System Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Preclinical In-vivo Imaging System Revenue Market Share by Application (2019-2024)
    Table 67. Global Preclinical In-vivo Imaging System Revenue Market Share by Application (2025-2030)
    Table 68. Global Preclinical In-vivo Imaging System Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Preclinical In-vivo Imaging System Price (USD/Unit) by Application (2025-2030)
    Table 70. Siemens A.G. Corporation Information
    Table 71. Siemens A.G. Description and Business Overview
    Table 72. Siemens A.G. Preclinical In-vivo Imaging System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Siemens A.G. Preclinical In-vivo Imaging System Product
    Table 74. Siemens A.G. Recent Developments/Updates
    Table 75. General Electric(GE) Corporation Information
    Table 76. General Electric(GE) Description and Business Overview
    Table 77. General Electric(GE) Preclinical In-vivo Imaging System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. General Electric(GE) Preclinical In-vivo Imaging System Product
    Table 79. General Electric(GE) Recent Developments/Updates
    Table 80. Agilent Technologies Corporation Information
    Table 81. Agilent Technologies Description and Business Overview
    Table 82. Agilent Technologies Preclinical In-vivo Imaging System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Agilent Technologies Preclinical In-vivo Imaging System Product
    Table 84. Agilent Technologies Recent Developments/Updates
    Table 85. FUJIFILM VisualSonics Corporation Information
    Table 86. FUJIFILM VisualSonics Description and Business Overview
    Table 87. FUJIFILM VisualSonics Preclinical In-vivo Imaging System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. FUJIFILM VisualSonics Preclinical In-vivo Imaging System Product
    Table 89. FUJIFILM VisualSonics Recent Developments/Updates
    Table 90. Aspect Imaging Corporation Information
    Table 91. Aspect Imaging Description and Business Overview
    Table 92. Aspect Imaging Preclinical In-vivo Imaging System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Aspect Imaging Preclinical In-vivo Imaging System Product
    Table 94. Aspect Imaging Recent Developments/Updates
    Table 95. Biospace Lab SA Corporation Information
    Table 96. Biospace Lab SA Description and Business Overview
    Table 97. Biospace Lab SA Preclinical In-vivo Imaging System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Biospace Lab SA Preclinical In-vivo Imaging System Product
    Table 99. Biospace Lab SA Recent Developments/Updates
    Table 100. Bruker Corporation Corporation Information
    Table 101. Bruker Corporation Description and Business Overview
    Table 102. Bruker Corporation Preclinical In-vivo Imaging System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Bruker Corporation Preclinical In-vivo Imaging System Product
    Table 104. Bruker Corporation Recent Developments/Updates
    Table 105. LI-COR Biosciences Corporation Information
    Table 106. LI-COR Biosciences Description and Business Overview
    Table 107. LI-COR Biosciences Preclinical In-vivo Imaging System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. LI-COR Biosciences Preclinical In-vivo Imaging System Product
    Table 109. LI-COR Biosciences Recent Developments/Updates
    Table 110. Mesoso Ltd. Corporation Information
    Table 111. Mesoso Ltd. Description and Business Overview
    Table 112. Mesoso Ltd. Preclinical In-vivo Imaging System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Mesoso Ltd. Preclinical In-vivo Imaging System Product
    Table 114. Mesoso Ltd. Recent Developments/Updates
    Table 115. MIlabs BV Corporation Information
    Table 116. MIlabs BV Description and Business Overview
    Table 117. MIlabs BV Preclinical In-vivo Imaging System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. MIlabs BV Preclinical In-vivo Imaging System Product
    Table 119. MIlabs BV Recent Developments/Updates
    Table 120. MR Solutions Ltd Corporation Information
    Table 121. MR Solutions Ltd Description and Business Overview
    Table 122. MR Solutions Ltd Preclinical In-vivo Imaging System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 123. MR Solutions Ltd Preclinical In-vivo Imaging System Product
    Table 124. MR Solutions Ltd Recent Developments/Updates
    Table 125. PerkinElmer Corporation Information
    Table 126. PerkinElmer Description and Business Overview
    Table 127. PerkinElmer Preclinical In-vivo Imaging System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 128. PerkinElmer Preclinical In-vivo Imaging System Product
    Table 129. PerkinElmer Recent Developments/Updates
    Table 130. TriFoil Imaging Corporation Information
    Table 131. TriFoil Imaging Description and Business Overview
    Table 132. TriFoil Imaging Preclinical In-vivo Imaging System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 133. TriFoil Imaging Preclinical In-vivo Imaging System Product
    Table 134. TriFoil Imaging Recent Developments/Updates
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Preclinical In-vivo Imaging System Distributors List
    Table 138. Preclinical In-vivo Imaging System Customers List
    Table 139. Preclinical In-vivo Imaging System Market Trends
    Table 140. Preclinical In-vivo Imaging System Market Drivers
    Table 141. Preclinical In-vivo Imaging System Market Challenges
    Table 142. Preclinical In-vivo Imaging System Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Preclinical In-vivo Imaging System
    Figure 2. Global Preclinical In-vivo Imaging System Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Preclinical In-vivo Imaging System Market Share by Type in 2023 & 2030
    Figure 4. Optical Imaging System Product Picture
    Figure 5. Nuclear Imaging System Product Picture
    Figure 6. Micro MRI System Product Picture
    Figure 7. Micro CT System Product Picture
    Figure 8. Micro Ultrasound System Product Picture
    Figure 9. Photoacoustic and Magnetic Particle Imaging Systems Product Picture
    Figure 10. Global Preclinical In-vivo Imaging System Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 11. Global Preclinical In-vivo Imaging System Market Share by Application in 2023 & 2030
    Figure 12. Hospitals
    Figure 13. Veterinary Clinics
    Figure 14. Laboratory
    Figure 15. Other
    Figure 16. Global Preclinical In-vivo Imaging System Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Preclinical In-vivo Imaging System Market Size (2019-2030) & (US$ Million)
    Figure 18. Global Preclinical In-vivo Imaging System Sales (2019-2030) & (K Units)
    Figure 19. Global Preclinical In-vivo Imaging System Average Price (USD/Unit) & (2019-2030)
    Figure 20. Preclinical In-vivo Imaging System Report Years Considered
    Figure 21. Preclinical In-vivo Imaging System Sales Share by Manufacturers in 2023
    Figure 22. Global Preclinical In-vivo Imaging System Revenue Share by Manufacturers in 2023
    Figure 23. The Global 5 and 10 Largest Preclinical In-vivo Imaging System Players: Market Share by Revenue in 2023
    Figure 24. Preclinical In-vivo Imaging System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 25. Global Preclinical In-vivo Imaging System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 26. North America Preclinical In-vivo Imaging System Sales Market Share by Country (2019-2030)
    Figure 27. North America Preclinical In-vivo Imaging System Revenue Market Share by Country (2019-2030)
    Figure 28. U.S. Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Canada Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Europe Preclinical In-vivo Imaging System Sales Market Share by Country (2019-2030)
    Figure 31. Europe Preclinical In-vivo Imaging System Revenue Market Share by Country (2019-2030)
    Figure 32. Germany Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. France Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. U.K. Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Italy Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Russia Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Asia Pacific Preclinical In-vivo Imaging System Sales Market Share by Region (2019-2030)
    Figure 38. Asia Pacific Preclinical In-vivo Imaging System Revenue Market Share by Region (2019-2030)
    Figure 39. China Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Japan Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. South Korea Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. India Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Australia Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Taiwan Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Indonesia Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Thailand Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Malaysia Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Philippines Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Latin America Preclinical In-vivo Imaging System Sales Market Share by Country (2019-2030)
    Figure 50. Latin America Preclinical In-vivo Imaging System Revenue Market Share by Country (2019-2030)
    Figure 51. Mexico Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Brazil Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Argentina Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Middle East & Africa Preclinical In-vivo Imaging System Sales Market Share by Country (2019-2030)
    Figure 55. Middle East & Africa Preclinical In-vivo Imaging System Revenue Market Share by Country (2019-2030)
    Figure 56. Turkey Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 58. U.A.E Preclinical In-vivo Imaging System Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 59. Global Sales Market Share of Preclinical In-vivo Imaging System by Type (2019-2030)
    Figure 60. Global Revenue Market Share of Preclinical In-vivo Imaging System by Type (2019-2030)
    Figure 61. Global Preclinical In-vivo Imaging System Price (USD/Unit) by Type (2019-2030)
    Figure 62. Global Sales Market Share of Preclinical In-vivo Imaging System by Application (2019-2030)
    Figure 63. Global Revenue Market Share of Preclinical In-vivo Imaging System by Application (2019-2030)
    Figure 64. Global Preclinical In-vivo Imaging System Price (USD/Unit) by Application (2019-2030)
    Figure 65. Preclinical In-vivo Imaging System Value Chain
    Figure 66. Preclinical In-vivo Imaging System Production Process
    Figure 67. Channels of Distribution (Direct Vs Distribution)
    Figure 68. Distributors Profiles
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Organic Industrial Antifungal Agents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-12J14669
Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical and Consumer Products Coding Equipment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-32H12616
Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Co-Packing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-13K12891
Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Nucleic Acid-based Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-27P12567
Tue Apr 30 00:00:00 UTC 2024

Add to Cart